Avolynt, Inc. is a clinical stage pharmaceutical company founded in 2015, specializing in the development of innovative therapeutics for the treatment of rare and metabolic diseases. Their primary focus lies within the Biotechnology and Health Care industries. Recently, the company received a significant $75.00K grant investment on 22 September 2022 from the One North Carolina Small Business Program. This notable injection of funds can potentially fuel their continued research and development efforts as they strive to make meaningful advancements in the field of pharmaceuticals.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $75.00K | 1 | One North Carolina Small Business Program | 22 Sep 2022 |
No recent news or press coverage available for Avolynt, Inc..
We care about your data, and we'd love to use cookies make your experience better.